全文获取类型
收费全文 | 1008篇 |
免费 | 44篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 72篇 |
妇产科学 | 8篇 |
基础医学 | 84篇 |
口腔科学 | 11篇 |
临床医学 | 88篇 |
内科学 | 449篇 |
皮肤病学 | 19篇 |
神经病学 | 31篇 |
特种医学 | 97篇 |
外科学 | 31篇 |
综合类 | 32篇 |
预防医学 | 21篇 |
眼科学 | 2篇 |
药学 | 33篇 |
中国医学 | 1篇 |
肿瘤学 | 73篇 |
出版年
2023年 | 3篇 |
2022年 | 5篇 |
2021年 | 3篇 |
2019年 | 5篇 |
2018年 | 8篇 |
2017年 | 10篇 |
2016年 | 12篇 |
2015年 | 17篇 |
2014年 | 16篇 |
2013年 | 30篇 |
2012年 | 20篇 |
2011年 | 20篇 |
2010年 | 38篇 |
2009年 | 25篇 |
2008年 | 30篇 |
2007年 | 37篇 |
2006年 | 38篇 |
2005年 | 30篇 |
2004年 | 45篇 |
2003年 | 32篇 |
2002年 | 48篇 |
2001年 | 44篇 |
2000年 | 33篇 |
1999年 | 27篇 |
1998年 | 26篇 |
1997年 | 36篇 |
1996年 | 29篇 |
1995年 | 33篇 |
1994年 | 27篇 |
1993年 | 38篇 |
1992年 | 17篇 |
1991年 | 13篇 |
1990年 | 24篇 |
1989年 | 31篇 |
1988年 | 33篇 |
1987年 | 19篇 |
1986年 | 29篇 |
1985年 | 22篇 |
1984年 | 13篇 |
1983年 | 7篇 |
1982年 | 11篇 |
1981年 | 16篇 |
1980年 | 12篇 |
1979年 | 6篇 |
1978年 | 6篇 |
1977年 | 9篇 |
1976年 | 12篇 |
1975年 | 4篇 |
1968年 | 1篇 |
1957年 | 1篇 |
排序方式: 共有1053条查询结果,搜索用时 203 毫秒
101.
102.
103.
Hartdorff Caroline M Frank Kneepkens CM van Dijk Alice EM Stok Anita Engels Michelle AH Gemke Reinoud JBJ Kindermann Angelika 《Tijdschrift voor kindergeneeskunde》2013,81(1):11-11
Tijdschrift voor Kindergeneeskunde - 相似文献
104.
105.
C M Gibson K A Ryan M Kelley M J Rizzo R Mesley S Murphy J Swanson S J Marble J T Dodge R P Giugliano C P Cannon E M Antman 《American heart journal》1999,137(6):1179-1184
BACKGROUND: The Thrombolysis in Myocardial Infarction (TIMI) Study Group originally defined TIMI grade 3 flow (complete perfusion) as antegrade flow into the bed distal to the obstruction that occurs as promptly as antegrade flow into the bed proximal to the obstruction. Recently, several groups have defined TIMI grade 3 flow as opacification of the coronary artery within 3 cardiac cycles. METHODS AND RESULTS: On the basis of heart rate data at the time of the cardiac catheterization and the time for dye to go down the artery (TIMI frame count/30 = seconds), we estimated the number of patients who would meet the 3 cardiac cycle criterion and compared this with the number of patients with TIMI grade 3 flow by using the original definition in 1157 patients from 3 recent TIMI trials (10 A, 10B, and 14). In 74 patients without acute myocardial infarction and normal coronary arteries, the fraction of a cardiac cycle required for dye to traverse the artery was a mean of 0.93 +/- 0.34 cardiac cycles (n = 74) (median 0.80, minimum 0.44, maximum 2.1, none >3.0 cycles). The mean heart rate at 90 minutes after thrombolysis in the TIMI 14 trial was 79.6 +/- 16.8 beats/min (n = 194), and the duration of 3 cardiac cycles was a mean of 2.36 seconds, or a TIMI frame count of 70.8 frames. In all trials, the rate of TIMI grade 3 flow was 57.3% (n = 663/1157) with the original definition and 66.8% (n = 743/1113) with the <3 cardiac cycle definition (P <.001). CONCLUSIONS: A duration of 3 cardiac cycles for dye to traverse the artery lies approximately 6 SD above that observed in normal coronary arteries. A 3 cardiac cycle definition of TIMI grade 3 flow results in rates of normal perfusion that are approximately 10% higher than if the original definition of TIMI grade 3 flow is applied. Application of this simple correction factor may help place data reported with the 3 cardiac cycle definition of TIMI grade 3 flow in context. 相似文献
106.
107.
108.
High-dose ifosfamide with mesna uroprotection: a phase I study 总被引:3,自引:0,他引:3
A D Elias J P Eder T Shea C B Begg E Frei K H Antman 《Journal of clinical oncology》1990,8(1):170-178
Phase II trials of ifosfamide have been performed with standard doses of 5 to 8 g/m2/course. In this phase I study, 29 patients were treated with a 4-day continuous infusion ifosfamide to determine the maximum-tolerated dose and the nonhematologic dose-limiting toxicity. Autologous bone marrow support was to have been used for the subsequent dose level if granulocytes were more than 500/microL for more than 14 days in two of two to five patients at a given dose level. Doses were escalated from 8 to 18 g/m2 ifosfamide. Mesna was given at an equivalent dose by continuous infusion for 5 days. At the 18 g/m2 dose level, dose-limiting renal insufficiency and a median of 11 days (range, 8 to 18 days) of granulocytopenia (less than 500/microL) were observed. Thus, autologous bone marrow reinfusion ws not used. The duration of myelosuppression, the frequency and severity of mucositis, and renal tubular acidosis were all dose-dependent. Mild to moderate CNS toxicity also appeared to be related to dose; however, severe CNS toxicity (transient confusion, hallucinations, and somnolence) was observed sporadically at both low- and high-dose levels. Transient hematuria (greater than 50 red blood cells [RBCs]/high power field) occurred once but did not affect treatment. There were nine responses (two complete) in 27 heavily pretreated assessable patients including seven responses in 20 patients with advanced refractory sarcoma. Ifosfamide with mesna uroprotection can undergo considerable dose escalation over the usual prescribed doses before nonhematologic dose-limiting toxicity is encountered. Ifosfamide has broad cytotoxicity against solid tumors and may prove to be an important addition to high-dose combination chemotherapy regimens. 相似文献
109.
Mary Lou Keohan Michael R. Grever Stanley P. Balcerzak Karen Antman 《Investigational new drugs》1997,15(3):255-256
Purpose and Methods: Bone and soft tissue sarcomas currently comprise 1% of adult malignancies and 15% of pediatric malignancies [1]. While doxorubicin and ifosfamide are active agents, no significant impact on survival has been observed. More active regimes are required in sarcoma. This trial studied cisplatin and a 5 day continuous infusion of vinblastine for patients who had had disease progression of advanced soft tissue sarcoma after a doxorubicin based regimen.Results: Between July 1983 and October 1986, 20 patients entered the study. There were no treatment related deaths. Seven patients required dose adjustment for neutropenia. No responses were observed. 相似文献
110.
S Singer K Antman J M Corson T J Eberlein 《Archives of surgery (Chicago, Ill. : 1960)》1992,127(5):548-53; discussion 553-4
Between 1971 and 1988, 39 patients were referred because of local recurrence of soft-tissue sarcomas and data from their patient records were analyzed to determine the parameters governing local recurrence. Mean follow-up was 11.1 years, with a mean time to local recurrence of 22 months. Twenty-one patients had local recurrence only, without metastatic disease. Salvage was provided for 14 (67%) of these patients after reexcision of local recurrence, and all 14 patients remained free of disease (mean follow-up, 112 months). We conclude that (1) excisional biopsy of tumors larger than 3 cm leads to potential contamination of clean tissue planes, limits ability to achieve an adequate margin of resection, and may compromise the definitive excision, and (2) in patients with local recurrence only, there is a high rate of long-term salvage (67% for follow-up of 9.3 years) after radical compartmental excision with or without postoperative radiation therapy. 相似文献